View Future GrowthNew Leaf Ventures 過去の業績過去 基準チェック /06New Leaf Venturesの過去数年間の業績に関するデータが不十分です。主要情報n/a収益成長率n/aEPS成長率Pharmaceuticals 業界の成長5.95%収益成長率n/a株主資本利益率n/aネット・マージンn/a前回の決算情報30 Sep 2023最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • Aug 01+ 1 more updateNew Leaf Ventures Announces Management ChangesNew Leaf Ventures Inc. announced the appointment of Mr. Dean Medwid as CEO and Director following the resignation of Mr. Michael Stier. Mr. Medwid formerly held the position of President and Chief Operating Officer of New Leaf Ventures Inc. Alongside this change, Mr. Christopher Cooper and Mr. Daryn Gordon have also tendered their resignations as members of New Leaf's board of directors. New Leaf has appointed Mr. Ryan Arthur to the board of directors and as Corporate Secretary. These changes reflect the Company's commitment to growth, innovation, and strategic vision. Additionally, Mr. Jason Garnett will continue with his role as Director and CSO for New Leaf and provide the needed continuity to maintain the momentum that the Company has created since his appointment. Mr. Arthur is currently the President of CR7 Investments Inc., which actively identifies prospective ventures for strategic investment, and technical partnerships, fostering their growth and prosperity. With a rich and diverse background encompassing retail, mining, Cannabis, industrial, and technology sectors, he brings a wealth of expertise to the table. Demonstrating his prowess in capital markets, Mr. Arthur has been instrumental in raising capital for numerous public companies. Additionally, his leadership extends to directorial positions at Nova Lithium Corp. and ISM Resources Corp. since 2021. Mr. Stier, Mr. Cooper, and Mr. Gordon for their invaluable contributions over the past several years, driving progress and success to date.お知らせ • Jan 14New Leaf Ventures Inc Announces Executive AppointmentsNew Leaf Ventures Inc. announced that Jason Garnett will be joining New Leaf's board of directors and initially acting as Chief Strategy Officer, while Dean Medwid will take on the role of President and Chief Operating Officer. Mr. Garnett is a serial entrepreneur and corporate executive with many years of experience founding and leading consumer packaged goods and beverage companies in Canada and the United States, including Seattle's Best Coffee Canada (acquired by Starbucks Corp. in 2007), e-grocery platform Spud.ca (operated by Freshlocal Solutions Inc.) and premium craft licensed producer Experion Biotechnologies Inc. (acquired by TSX-listed The Valens Company Inc. in 2021). Over his nearly 30-year career, he has been recognized with numerous business awards and accolades, including Profit 100's Top 100 in Canada five years in a row, BC Business Top 30 Under 30 and Top 40 Under 40, as well as a finalist for Ernst & Young's Entrepreneur of the Year. Mr. Garnett currently serves as CEO and a director of CSE-listed Xebra Brands Ltd. Mr. Medwid is a dynamic senior operation executive with more than 30 years of experience in both public and private markets with a focus on scalable process engineering, brand development and strategic partnerships. He has been recognized with numerous business awards and accolades, including Profit 100's Top 100 in Canada five years in a row while a partner in Seattle's Best Coffee Canada, and was recognized as one of Business in Vancouver's Top 40 Under 40. Mr. Medwid has a demonstrated history of increasing corporate performance through the management of process design, customer relationships and strategic planning along with a focused initiative of data-driven change management. Mr. Medwid utilized these skills to help lead Altrom, a division of a large public company. He recently launched Fourth Dimension Bio-tech, a supplements company focused on manufacturing consumer products utilizing specific cannabis generated isolates to support daily health regimes.お知らせ • Jan 13New Leaf Ventures Inc (CNSX:NLV) completed the acquisition of High Profile Holdings Corp.New Leaf Ventures Inc (CNSX:NLV) entered into letter of Intent to acquire High Profile Holdings Corp. on October 3, 2022. New Leaf Ventures Inc (CNSX:NLV) agreed to acquire High Profile Holdings Corp. for CAD 2.7 million on December 21, 2022. High Profile will be entitled to nominate one director for appointment to the New Leaf board of directors, subject to approval of the Canadian Securities Exchange. New Leaf will issue 0.052548929 of a common share (each whole share, a “Common Share”) for each issued and outstanding common share of High Profile, and the common shares of High Profile will be cancelled, resulting in the issuance of approximately 10,000,000 Common Shares as total transaction consideration. High Profile will amalgamate with a wholly-owned subsidiary of New Leaf under the Business Corporations Act (British Columbia) and the amalgamated entity will continue as a wholly-owned subsidiary of New Leaf under the name “High Profile Holdings Cannabis Corp.” The Common Shares issued to the former High Profile shareholders will be subject to a 24-month lock-up schedule, with 10% released from lock-up on closing of the Acquisition (“Closing”), 15% released six months from Closing, 20% released 12 months from Closing, 25% released 18 months from Closing and the remaining 30% released 24 months from Closing. Outstanding share purchase warrants of High Profile will remain outstanding on Closing and will remain exercisable to acquire Common Shares in accordance with their adjustment provisions. The Acquisition is subject to a number of conditions, including customary due diligence and the execution of a definitive agreement. Completion of the Acquisition is subject to shareholder approval for the Acquisition by the shareholders of High Profile, as well as receipt of regulatory approvals and other customary closing conditions. High Profile is expected to hold a shareholder meeting to seek approval for the Acquisition in early January, 2023. New Leaf Ventures Inc (CNSX:NLV) completed the acquisition of High Profile Holdings Corp. on January 12, 2023. Jason Garnett will be joining New Leaf’s board of directors and initially acting as Chief Strategy Officer, while Dean Medwid will take on the role of President and Chief Operating Officer. Boris Gorodnitsky resigned.収支内訳New Leaf Ventures の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:NLVV.F 収益、費用、利益 ( )CAD Millions日付収益収益G+A経費研究開発費30 Sep 231-64030 Jun 232-64031 Mar 232-54031 Dec 222-43030 Sep 22202030 Jun 222-13031 Mar 222-24031 Dec 212-45030 Sep 213-84030 Jun 213-74031 Mar 213-83031 Dec 202-72030 Sep 201-32030 Jun 201-32031 Mar 200-11031 Dec 190-11030 Sep 190-110質の高い収益: NLVV.Fが 高品質の収益 を有しているかどうかを判断するにはデータが不十分です。利益率の向上: NLVV.Fの 利益率 が過去 1 年間で改善したかどうかを判断するにはデータが不十分です。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: NLVV.Fの過去 5 年間の前年比収益成長率がプラスであったかどうかを判断するにはデータが不十分です。成長の加速: NLVV.Fの過去 1 年間の収益成長を 5 年間の平均と比較するにはデータが不十分です。収益対業界: NLVV.Fの過去 1 年間の収益成長がPharmaceuticals業界平均を上回ったかどうかを判断するにはデータが不十分です。株主資本利益率高いROE: NLVV.Fは現在利益が出ていないため、自己資本利益率 ( 0% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 16:17終値2026/04/13 00:00収益2023/09/30年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋New Leaf Ventures Inc 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Aug 01+ 1 more updateNew Leaf Ventures Announces Management ChangesNew Leaf Ventures Inc. announced the appointment of Mr. Dean Medwid as CEO and Director following the resignation of Mr. Michael Stier. Mr. Medwid formerly held the position of President and Chief Operating Officer of New Leaf Ventures Inc. Alongside this change, Mr. Christopher Cooper and Mr. Daryn Gordon have also tendered their resignations as members of New Leaf's board of directors. New Leaf has appointed Mr. Ryan Arthur to the board of directors and as Corporate Secretary. These changes reflect the Company's commitment to growth, innovation, and strategic vision. Additionally, Mr. Jason Garnett will continue with his role as Director and CSO for New Leaf and provide the needed continuity to maintain the momentum that the Company has created since his appointment. Mr. Arthur is currently the President of CR7 Investments Inc., which actively identifies prospective ventures for strategic investment, and technical partnerships, fostering their growth and prosperity. With a rich and diverse background encompassing retail, mining, Cannabis, industrial, and technology sectors, he brings a wealth of expertise to the table. Demonstrating his prowess in capital markets, Mr. Arthur has been instrumental in raising capital for numerous public companies. Additionally, his leadership extends to directorial positions at Nova Lithium Corp. and ISM Resources Corp. since 2021. Mr. Stier, Mr. Cooper, and Mr. Gordon for their invaluable contributions over the past several years, driving progress and success to date.
お知らせ • Jan 14New Leaf Ventures Inc Announces Executive AppointmentsNew Leaf Ventures Inc. announced that Jason Garnett will be joining New Leaf's board of directors and initially acting as Chief Strategy Officer, while Dean Medwid will take on the role of President and Chief Operating Officer. Mr. Garnett is a serial entrepreneur and corporate executive with many years of experience founding and leading consumer packaged goods and beverage companies in Canada and the United States, including Seattle's Best Coffee Canada (acquired by Starbucks Corp. in 2007), e-grocery platform Spud.ca (operated by Freshlocal Solutions Inc.) and premium craft licensed producer Experion Biotechnologies Inc. (acquired by TSX-listed The Valens Company Inc. in 2021). Over his nearly 30-year career, he has been recognized with numerous business awards and accolades, including Profit 100's Top 100 in Canada five years in a row, BC Business Top 30 Under 30 and Top 40 Under 40, as well as a finalist for Ernst & Young's Entrepreneur of the Year. Mr. Garnett currently serves as CEO and a director of CSE-listed Xebra Brands Ltd. Mr. Medwid is a dynamic senior operation executive with more than 30 years of experience in both public and private markets with a focus on scalable process engineering, brand development and strategic partnerships. He has been recognized with numerous business awards and accolades, including Profit 100's Top 100 in Canada five years in a row while a partner in Seattle's Best Coffee Canada, and was recognized as one of Business in Vancouver's Top 40 Under 40. Mr. Medwid has a demonstrated history of increasing corporate performance through the management of process design, customer relationships and strategic planning along with a focused initiative of data-driven change management. Mr. Medwid utilized these skills to help lead Altrom, a division of a large public company. He recently launched Fourth Dimension Bio-tech, a supplements company focused on manufacturing consumer products utilizing specific cannabis generated isolates to support daily health regimes.
お知らせ • Jan 13New Leaf Ventures Inc (CNSX:NLV) completed the acquisition of High Profile Holdings Corp.New Leaf Ventures Inc (CNSX:NLV) entered into letter of Intent to acquire High Profile Holdings Corp. on October 3, 2022. New Leaf Ventures Inc (CNSX:NLV) agreed to acquire High Profile Holdings Corp. for CAD 2.7 million on December 21, 2022. High Profile will be entitled to nominate one director for appointment to the New Leaf board of directors, subject to approval of the Canadian Securities Exchange. New Leaf will issue 0.052548929 of a common share (each whole share, a “Common Share”) for each issued and outstanding common share of High Profile, and the common shares of High Profile will be cancelled, resulting in the issuance of approximately 10,000,000 Common Shares as total transaction consideration. High Profile will amalgamate with a wholly-owned subsidiary of New Leaf under the Business Corporations Act (British Columbia) and the amalgamated entity will continue as a wholly-owned subsidiary of New Leaf under the name “High Profile Holdings Cannabis Corp.” The Common Shares issued to the former High Profile shareholders will be subject to a 24-month lock-up schedule, with 10% released from lock-up on closing of the Acquisition (“Closing”), 15% released six months from Closing, 20% released 12 months from Closing, 25% released 18 months from Closing and the remaining 30% released 24 months from Closing. Outstanding share purchase warrants of High Profile will remain outstanding on Closing and will remain exercisable to acquire Common Shares in accordance with their adjustment provisions. The Acquisition is subject to a number of conditions, including customary due diligence and the execution of a definitive agreement. Completion of the Acquisition is subject to shareholder approval for the Acquisition by the shareholders of High Profile, as well as receipt of regulatory approvals and other customary closing conditions. High Profile is expected to hold a shareholder meeting to seek approval for the Acquisition in early January, 2023. New Leaf Ventures Inc (CNSX:NLV) completed the acquisition of High Profile Holdings Corp. on January 12, 2023. Jason Garnett will be joining New Leaf’s board of directors and initially acting as Chief Strategy Officer, while Dean Medwid will take on the role of President and Chief Operating Officer. Boris Gorodnitsky resigned.